ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RENX Renalytix Plc

33.50
-1.50 (-4.29%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Renalytix Plc LSE:RENX London Ordinary Share GB00BYWL4Y04 ORD 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.50 -4.29% 33.50 92,711 16:26:48
Bid Price Offer Price High Price Low Price Open Price
32.00 35.00 35.00 33.50 35.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Services, Nec USD 3.4M USD -46.22M USD -0.4626 -0.72 33.48M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:28:15 O 8,047 33.50 GBX

Renalytix (RENX) Latest News (3)

Renalytix (RENX) Discussions and Chat

Renalytix (RENX) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Renalytix (RENX) Top Chat Posts

Top Posts
Posted at 29/3/2024 08:20 by Renalytix Daily Update
Renalytix Plc is listed in the Services, Nec sector of the London Stock Exchange with ticker RENX. The last closing price for Renalytix was 35p.
Renalytix currently has 99,930,156 shares in issue. The market capitalisation of Renalytix is £33,476,602.
Renalytix has a price to earnings ratio (PE ratio) of -0.72.
This morning RENX shares opened at 35p
Posted at 13/3/2024 14:28 by 1jat
I am encouraged the founders/champions of RENX have bought into the fund raise…..but they are the funder of last resort at the moment.

The fund raise provides an immediate stay of execution for the company and will allow the sale of business process to proceed without a gun to the directors heads….however they need to recognise that either they will need to sell the business or be prepared to fund the company until it can make itself cash generative.

They must hope the continued adoption in clinical standards will result in substantial demand for tests. That is what gives me hope that they can land a decent offer and sell the company.
Posted at 12/3/2024 09:53 by faz
Good to see Howard Doran appointed as Business Manager to drive sales all of six months ago doesnt even list RENX as his employer. Fact he's yet another one in his mid 60s picking up a pension salary here probably means he's forgotten where he works. They know how to pick them
Posted at 12/3/2024 07:42 by mortal1ty
Told you:

mortal1ty: Seen this so many times before.

Compnay on its last legs, and needing capital.

Vague bid spec, followed by formal sales process.

Bid rarely comes. Sometimes if it does come it is at a price well below the current price.

If it doesn't come emergency funding needed and business collapses.
Posted at 05/3/2024 10:49 by 1jat
The $64m question (gosh that used to be an awful lot of money)….is the price at which a deal can be struck. With 100m shares in issue each £1m is roughly 1p to shareholders.
You would think a large diagnostic company would know how to exploit the product and evaluate its prospects….they can afford not to overpay as this is a forced sale…if it were the UK, I would expect a pre-pack administration (not that there are many debts to write off - as I dare say they will all convert to equity).

The Directors can really only resist if they have a viable plan B (until recently plan A that they have not been able/willing to execute).

I need 125p to break even in my small speculative investment here…..I expect a significant loss, anything less than 50% is looking good now as it was down to a 95% loss at one point.
Posted at 04/3/2024 12:43 by faz
For those about to be duped by rampers, the USA price includes 2 shares - so halve it. And then do some sums, you only need half a brain.
Posted at 04/3/2024 10:07 by faz
THe product doesnt sell, the company has no cash, nor seemingly can they raise finance- hence the distressed sale. Please someone take this off our hands - I would not expect the sale to be at a premium to the cu8rrent price, and likely to be less. As a punt its over - any value is in the current price and then some imo
Posted at 04/3/2024 08:56 by beatme1
Price too high now for decent trade.
Posted at 04/3/2024 07:12 by mortal1ty
Seen this so many times before.

Compnay on its last legs, and needing capital.

Vague bid spec, followed by formal sales process.

Bid rarely comes. Sometimes if it does come it is at a price well below the current price.

If it doesn't come emergency funding needed and business collapses.
Posted at 14/11/2023 11:20 by idomeneo
"74tom - 15 Mar 2022 - 12:57:11 - 1692 of 2344 Renalytix - AI Solutions Transforming The Management Of Kidney Disease - RENX
Idomeneo, your posts remind me of a troll on a football forum pretending to support a team when they actually hate them. What you are saying is akin to going on a Spurs forum and posting that you think Harry Kane will leave on a free transfer or that he's going to retire at 28 to focus on other opportunities.

It's complete nonsense to suggest RENX will run out of money, just like it was nonsense to say that raising $50m will double the share count or that shorters are here because they think RENX is like Theranos. Nobody who was invested here would be talking such rubbish, so please quit with the 'we' and go find something else to troll!"


This was at £2.50 6 months after the 50 day and the 200 day had rolled over, the company had repeatedly claimed x was going to happen and it subsequently didn't. This guy went on to attack Paul Scott who has been a successful investor analysing several hundred companies a year for over 20 years and has unearthed many multi-baggers over that time. You get the same people who latch onto a stock and attack anybody else with a different view. As an investor you should be interested in looking at all the negatives of your investment, ideally this would be a place where that happens, but it never has. Where somebody would say " you are wrong for these reasons...". NB I didn't mention Theranos because it was a fraud and not relevant here, so he wrongly inferred that.
Posted at 13/7/2023 12:11 by mikemine1
Correct me if I'm wrong but RENX has reached practically all it's milestones now except breakeven point. FDA was the last major hurdle even though that didn't stop the company gaining multiple insurance acceptances and recognition of the validity of it's product without it. It even has a link up with a huge sales outlet that should propel the revenue stream quicker than RENX could do themselves.

It's all good to me and we only need to have a bit more patience to see what happens in the next 6 months. I also note the increased interest which has pushed the share price to the £1.40 mark from sub £1.00.

Lots of reasons to be happy IMHO and lots of potential upside for the share price I reckon.
Renalytix share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock